 TORONTO, Nov. 05, 2020 GLOBE NEWSWIRE -- Profound Medical Corp. NASDAQ:PROF; TSX:PRN Profound or the Company, the only company to provide customizable, incision-free therapies which combine real-time Magnetic Resonance Imaging MRI, thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue, today reported financial results for the third quarter ended September 30, 2020, and provided an update on its operations. 